Hinge Health (HNGE) Stock Price, News & Analysis

Company Overview

Hinge Health, Inc. is a digital health company focused on musculoskeletal care. The company provides virtual programs designed to help people manage and improve conditions affecting the back, joints and other areas of the musculoskeletal system, with the goal of supporting conservative care and reducing the need for more invasive treatment.

Its platform combines personalized exercise therapy, digital tools, clinical guidance and behavioral support. Depending on the program, members may use the Hinge Health mobile application, wearable motion sensors and remote care from physical therapists, health coaches and other clinicians. The company also offers programs addressing areas such as chronic pain, joint health and pelvic health.

Hinge Health was founded in 2015 and primarily serves members through employer and health plan relationships in the United States. The company is led by co-founder and Chief Executive Officer Daniel Perez.

Key Stats

• Today's Range: $90.34 to $93.60
• 50-Day Range: $74.21 to $95.11
• 52-Week Range: $30.08 to $96.66
• Volume: 2.30 million shs
• Average Volume: 1.90 million shs
• Market Capitalization: $7.43 billion
• P/E Ratio: 71.98
• Dividend Yield: N/A
• Price Target: $103.71
• Consensus Rating: Moderate Buy

Hinge Health Stock Analysis - MarketRank™

Hinge Health scored higher than 77% of companies evaluated by MarketBeat, and ranked 183rd out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Hinge Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 1 strong buy rating, 14 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

Hinge Health has a consensus price target of $103.71, representing about 12.6% upside from its current price of $92.13.

Amount of Analyst Coverage

Hinge Health has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 8.80%

Earnings Growth

Earnings for Hinge Health are expected to grow by 8.80% in the coming year, from $1.25 to $1.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Hinge Health is 71.98, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.92.

Price to Earnings Ratio vs. Sector

The P/E ratio of Hinge Health is 71.98, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.41.

Price to Book Value per Share Ratio

Hinge Health has a P/B Ratio of 40.77. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

7.38% of the float of Hinge Health has been sold short.

Short Interest Ratio / Days to Cover

Hinge Health has a short interest ratio ("days to cover") of 2.65, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Hinge Health has recently decreased by 11.20%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Hinge Health does not currently pay a dividend.

Dividend Growth

Hinge Health does not have a long track record of dividend growth.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.46

News Sentiment

Hinge Health has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for Hinge Health this week, compared to 4 articles on an average week.

Search Interest

14 people have searched for HNGE on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.

MarketBeat Follows

Only 11 people have added Hinge Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -15% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Hinge Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $274,829,253.00 in company stock.

Percentage Held by Insiders

18.92% of the stock of Hinge Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Hinge Health has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 9/24/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NYSE:HNGE
• Previous Symbol: NYSE:HNGE
• CIK: 1673743
• Web: www.hingehealth.com
• Phone: (415) 689-8429
• Fax: N/A
• Employees: 1,437
• Year Founded: 2014

Price Target and Rating

• Average Price Target for Hinge Health: $103.71
• High Price Target: $125.00
• Low Price Target: $80.00
• Potential Upside/Downside: +12.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.89
• Research Coverage: 18 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.28
• Trailing P/E Ratio: 71.98
• Forward P/E Ratio: 73.71
• P/E Growth: N/A
• Net Income: -$528.26 million
• Net Margins: 15.15%
• Pretax Margin: 15.41%
• Return on Equity: 51.60%
• Return on Assets: 14.16%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.34
• Quick Ratio: 1.30

Sales & Book Value

• Annual Sales: $587.86 million
• Price / Sales: 12.65
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.26 per share
• Price / Book: 40.77

Miscellaneous

• Outstanding Shares: 80,690,000
• Free Float: 65,427,000
• Market Cap: $7.43 billion
• Optionable: N/A
• Beta: 1.38